These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 425395)

  • 1. [Immune reactions in assessing the disease prognosis in soft tissue sarcomas].
    Klimenkov AA; Kadagidze ZG; Gladikov IuV
    Vopr Onkol; 1979; 25(1):3-8. PubMed ID: 425395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and immunological parallels in soft tissue tumors].
    Gladikov IuV; Klimenkov AA; Kadagidze ZG; Kupin VI; Sveshinina IuA
    Vopr Onkol; 1978; 24(12):3-8. PubMed ID: 735006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity reaction in patients with bone and soft tissue sarcoma.
    Shinohara N; Fukuma H; Nishio A
    Nihon Seikeigeka Gakkai Zasshi; 1979 Jun; 53(6):705-11. PubMed ID: 490017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic reactions in patients with soft tissue sarcomas after surgical treatment].
    Malysheva SF; Romanova OA; Slivinskaia ZP
    Vopr Onkol; 1978; 24(11):30-5. PubMed ID: 741697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune-status in patients with bone and soft-tissue sarcomas.
    Kotz R; Rella W; Salzer M
    Recent Results Cancer Res; 1976; (54):197-205. PubMed ID: 1070721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
    Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological reactivity study of patients with uterine trophoblastic tumors].
    Grigorova TM; Stas TA; Kadagidze ZG; Kovaleva VL
    Vopr Onkol; 1979; 25(7):86-90. PubMed ID: 225875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed hypersensitivity to staphylococcal antigens in patients with staphylodermas].
    Lesnitskiĭ AI
    Vestn Dermatol Venerol; 1990; (1):46-53. PubMed ID: 2327171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune response in the course of Kaposi's sarcoma].
    Scalise G; Mura MS; Piersimoni C; Manca S; Cherchi G; Andreoni G
    Boll Ist Sieroter Milan; 1980; 59(6):632-7. PubMed ID: 7236363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local recurrences of soft tissue sarcomas in adults: a retrospective analysis of prognostic factors in 102 cases after surgery and radiotherapy].
    Dinges S; Budach V; Budach W; Feldmann HJ; Stuschke M; Sack H
    Strahlenther Onkol; 1996 Feb; 172(2):106-7. PubMed ID: 8669041
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of immunologic tests in cancer of the oral cavity].
    Szpirglas H; Castet-Sardjveladzé E; Piadé R; Roth-Ghanassia V; Tsamis J
    Rev Stomatol Chir Maxillofac; 1977; 78(3):207-18. PubMed ID: 329403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic aspects of human sarcomas.
    Pritchard DJ; Ivins JC; Ritis RE
    Recent Results Cancer Res; 1976; (54):185-96. PubMed ID: 796919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.